Doing science isn't always about going to the lab, creating experiments and researching new ways to cure cancer, DrugMonkey says. Sometimes it involves writing endless grant proposals and trying to secure new sources of funding. When he first began his life as a researcher, DrugMonkey says he wasn't at all concerned with his "career" and was more focused on "doing the science I wanted to do and following the steps" of grad school and a postdoc.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.